Positioning Statements on Physician-led Switching for Biosimilar Medicines

Second wave pandemic preparedness: procurement principles

Policy Roadmap for Medicines Manufacturing Leadership

Call for tenders SANTE/2020/C3/29 for the supply of medicinal products used for intensive care patients subject to the novel coronavirus (COVID-19) disease – policy and technical concerns

Preparing for a potential second COVID-19 wave. Joint statement by Medicines for Europe and EFPIA with Kearney

LESSONS LEARNED FROM COVID-19 – POLICY PAPER

Position Paper. Reference safety information: challenges to the generic industry due to labelling harmonisation issues among different Member States

Position Paper. Incentives Review The Orphan and Paediatric Incentives

The secret to improve access to value added medicines

A digital future for value added medicines